October 25, 2020

The Niche

Knoepfler lab stem cell blog

iPS cell patent war

3 min read

Will intellectual property (IP) wars over patent rights to one of the most exciting new stem cell technologies hold back getting novel therapies to patients such as IPS cells? Unfortunately, it’s very possible. Induced pluripotent stem (iPS) cells are very cool stem cells made from non-stem cells through a process called cellular reprogramming. iPS  cells have essentially all of the same properties and powers as embryonic stem (ES) cells, but without the potential ethical complexity of utlizing a human blastocyst for their generation. Pretty amazing, …Read More